
Levedia Pharmaceuticals Private Limited
Founded in 2014 and headquartered in Gujarat, India.
Founded in 2014 and headquartered in Gujarat, India.
Ahmedabad, Gujarat, India
+91-XXXXXXXXXX
U24232GJ2014PTC078877
078877
Private Limited Indian Non-Government Company
24 Feb 2014
29 Sep 2017
31 Mar 2017
Unlisted
Roc Ahmedabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nirmal Aggarwal ![]() | Director | 01-Sep-2017 | Current |
Shubhra Singh ![]() | Director | 01-Sep-2017 | Current |
Levedia Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Levedia Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Levedia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Levedia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Levedia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Levedia Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records.
Nirmal Aggarwal was appointed as a Director was appointed as a Director on 01 Sep 2017 & has been associated with this company since 7 years 9 months .
Shubhra Singh was appointed as a Director was appointed as a Director on 01 Sep 2017 & has been associated with this company since 7 years 9 months .
Levedia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Ahmedabad.
Levedia Pharmaceuticals Private Limited was registered on 24 Feb 2014 with Roc Ahmedabad & aged 11 years 3 months as per MCA records.
Levedia Pharmaceuticals Private Limited was incorporated on 24 Feb 2014.
The authorized share capital of Levedia Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Levedia Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Levedia Pharmaceuticals Private Limited is Shop No.3 Palm Plaza Building Near Torrent Power, Sub Station Makarba Road Vejalpur, Ahmedabad, Gujarat, India, 380051.
The corporate identification number (CIN) of Levedia Pharmaceuticals Private Limited is U24232GJ2014PTC078877 and the company number is 078877 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Levedia Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2017.
Search company & director profiles for free and gain access to critical business data.
AS